INNPF (InnoCan Pharma) Total Assets : $9.26 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is InnoCan Pharma Total Assets?

InnoCan Pharma's Total Assets for the quarter that ended in Dec. 2024 was $9.26 Mil.

During the past 12 months, InnoCan Pharma's average Total Assets Growth Rate was 47.80% per year. During the past 3 years, the average Total Assets Growth Rate was 45.80% per year. During the past 5 years, the average Total Assets Growth Rate was 40.40% per year.

During the past 7 years, InnoCan Pharma's highest 3-Year average Total Assets Growth Rate was 50.90%. The lowest was 17.10%. And the median was 47.05%.

Total Assets is connected with ROA %. InnoCan Pharma's annualized ROA % for the quarter that ended in Dec. 2024 was -4.84%. Total Assets is also linked to Revenue through Asset Turnover. InnoCan Pharma's Asset Turnover for the quarter that ended in Dec. 2024 was 0.57.

InnoCan Pharma Total Assets Historical Data

The historical data trend for InnoCan Pharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Total Assets Chart

InnoCan Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

4.33

12.58

6.98

6.94

9.26

InnoCan Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial															6.94	9.04	8.72	9.60	9.26

InnoCan Pharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

InnoCan Pharma's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	7.022	+	2.238
	=	9.26

InnoCan Pharma's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	7.022	+	2.238
	=	9.26

InnoCan Pharma (OTCPK:INNPF) Total Assets Explanation

Total Assets is connected with ROA %.

InnoCan Pharma's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	-0.456	/	( (9.595	+	9.26)	/ 2 )
	=	-0.456	/	9.4275
	=	-4.84 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

InnoCan Pharma's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	5.401	/	( (9.595	+	9.26)	/ 2 )
=	5.401	/	9.4275
=	0.57

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

InnoCan Pharma Total Assets Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCan Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (OTCPK:INNPF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

IP4:Germany INNO:Canada

Address

1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7

Website

https://www.innocanpharma.com

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.